EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications

Wout Arras iD, Baptiste Oosterlinck iD, Julie Gassman iD, Joris G De Man iD, Aranzazu Jauregui-Amezaga iD, Benedicte Y De Winter iD, Annemieke Smet iD

Inflammatory Bowel Diseases · 01.02.2026 · 32 (2) · 375-389

DOI: 10.1093/ibd/izaf293 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 24.11.2025. Verfasst von Wout Arras und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Inflammatory Bowel Diseases, Mucins, Polymorphism, Genetic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Antwerp University Valorisation Funds, the Research Foundation Flanders, Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The intestinal mucosal barrier plays an important role in the pathophysiology of inflammatory bowel disease (IBD), with mucins being key components of this barrier. Classified as either transmembrane or secreted, these highly glycosylated proteins protect the mucosal barrier while also influencing barrier integrity. Given their indispensable role in maintaining the intestinal mucosal barrier, mucins are compelling candidates for the evaluation of barrier dysfunction. Numerous studies have investigated mucins in the context of IBD, but a clear consensus regarding their expression, polymorphisms, and post-translational modifications is missing. This systematic review summarizes mucin alterations at the transcriptional, translational, and post-translational levels in the presence/absence of intestinal inflammation in IBD patients.

Methods

To this end, PubMed, Scopus, and Web of Science were searched for studies published between February 1993 and January 2025, yielding 69 articles eligible for inclusion.

Results

The expression of MUC1, MUC5AC, and MUC6 was reported to be upregulated at both RNA (isoform) and protein level, in contrast to MUC12, which exhibited reduced expression in inflamed mucosa only at RNA isoform level. MUC2 was the only mucin consistently downregulated at the protein level, despite unchanged mRNA expression, whereas polymorphisms of MUC2, MUC3A, MUC4, MUC13, MUC19, MUC21, and MUC22 were associated with susceptibility to Crohn’s disease, ulcerative colitis, or IBD in general. Post-translational modifications, such as hypoglycosylation of MUC1 and MUC2, as well as a reduction of mucin sulphation of MUC2 were reported.

Conclusion

Together, these findings underscore the involvement of mucins in IBD and point to their potential as biomarkers for barrier dysfunction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Processing, Post-TranslationalInflammatory Bowel DiseasesMucinsPolymorphism, GeneticIntestinal MucosaHumansClinical Relevance

Stichwörter der Autor:innen

Crohn’s diseaseinflammatory bowel diseaseintestinal mucosal barriermucinsulcerative colitis

Substanzen

Mucins

Autor:innen und Institutionen

  • Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Infla-Med, Centre of Excellence, University of Antwerp, Antwerp, Belgium.
  • Division of Gastroenterology and Hepatology, Antwerp University Hospital, Edegem, Belgium.

ORCID-Profile: Wout Arras, Baptiste Oosterlinck, Julie Gassman, Joris G De Man, Aranzazu Jauregui-Amezaga, Benedicte Y De Winter, Annemieke Smet

Förderung

  • Antwerp University Valorisation Funds
  • the Research Foundation Flanders
  • Research Foundation Flanders

Zitieren

APA

Arras, W., Oosterlinck, B., Gassman, J., De Man, J. G., Jauregui-Amezaga, A., De Winter, B. Y., & Smet, A. (2026). Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications. Inflammatory Bowel Diseases, 32(2), 375-389. https://doi.org/10.1093/ibd/izaf293

Vancouver

Arras W, Oosterlinck B, Gassman J, De Man JG, Jauregui-Amezaga A, De Winter BY, et al. Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications. Inflammatory Bowel Diseases. 2026;32(2):375-389. doi:10.1093/ibd/izaf293

BibTeX
@article{Arras2026,
  author = {Arras, Wout and Oosterlinck, Baptiste and Gassman, Julie and De Man, Joris G and Jauregui-Amezaga, Aranzazu and De Winter, Benedicte Y and Smet, Annemieke},
  title = {Clinical Significance of Mucin Signatures in Inflammatory Bowel Diseases: A Systematic Review of Their Expression Patterns, Polymorphisms, and Post-translational Modifications},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  volume = {32},
  number = {2},
  pages = {375--389},
  doi = {10.1093/ibd/izaf293}
}
Kostenlos starten →